{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":50,"n_cols":5,"rows_kept":50,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[11,2,11,3],[13,2,13,3],[19,2,19,3],[19,4,19,5],[20,2,20,3],[20,4,20,5],[21,2,21,3],[21,4,21,5],[22,2,22,3],[23,2,23,3],[24,2,24,3],[25,2,25,3],[26,2,26,3],[27,2,27,3],[28,2,28,3],[44,2,44,3],[45,2,45,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910467437803321"]
[null,null,"Autore",null,"Brizzi Kate T."]
[null,null,"Titolo",null,"Neurology evidence : the practice-changing studies / / Kate T. Brizzi [and three others]"]
[null,null,"Pubbl/distr/stampa",null,"Philadelphia : , : Wolters Kluwer, , [2017]"]
[{"$nulls":4},"©2017"]
[null,null,"ISBN",null,"1-4963-4895-8"]
[null,null,"Descrizione fisica",null,"1 online resource (337 pages)"]
[null,null,"Disciplina",null,"616.8046"]
[null,null,"Soggetti",null,"Nervous system - Diseases - Treatment"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Intro -- Title Page -- Copyright -- DEDICATION -- CONTRIBUTORS -- FOREWORD -- PREFACE -- ACKNOWLEDGMENTS -- CONTENTS -- SECTION 1: ISCHEMIC STROKE -- 1. Intravenous tPA for Acute Ischemic Stroke -- 2. Aspirin for Secondary Stroke Prevention -- 3. Mechanical Thrombectomy for Large Vessel Occlusion -- 4. Harm from Stenting of Symptomatic Intracranial Arterial Stenoses -- 5. Warfarin for Atrial Fibrillation -- 6. Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation -- 7. Intense Low-Density Lipoprotein Cholesterol Reduction for Stroke Prevention -- 8. Marginal Benefit from Device Closure of Patent Foramen Ovale -- 9. Early Decompressive Surgery in Malignant Infarction of the Middle Cerebral Artery -- 10. Carotid Endarterectomy for Stroke Prevention in Internal Carotid Artery Stenosis -- 11. Carotid Artery Stenting vs. Carotid Endarterectomy For Symptomatic and Asymptomatic Carotid Artery Stenosis -- 12. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm -- 13. Short-Term Dual Antiplatelet Therapy for Stroke Prevention after TIA or Minor Stroke -- 14. Aspirin Over Warfarin for Symptomatic Intracranial Stenosis -- 15. Lack of Benefit from Long-Term Dual Antiplatelet Therapy for Secondary Stroke Prevention -- 16. Fluoxetine for Motor Recovery after Acute Ischemic Stroke -- 17. Carotid Endarterectomy for Asymptomatic Carotid Artery Stenosis -- 18. Extended Monitoring for Paroxysmal Atrial Fibrillation -- 19. The National Institutes of Health Stroke Scale -- SECTION 2: CEREBRAL HEMORRHAGE -- 20. Blood Pressure Regulation in Parenchymal Intracerebral Hemorrhage -- 21. Early Surgery for Spontaneous Intracerebral Hemorrhage and "]
[{"$nulls":4},"Hydrocephalus -- 22. Avoidance of Long-Term Anticoagulation for Atrial Fibrillation after Intracerebral Hemorrhage."]
[{"$nulls":4},"23. Nimodipine for Prevention of Delayed Neurologic Injury after Subarachnoid Hemorrhage -- 24. Inferiority of Surgical Resection to Medical Management of Unruptured AVM -- 25. Prognostication for Intracerebral Hemorrhage -- 26. Acute Endovascular Treatment for Ruptured Subarachnoid Hemorrhage -- 27. Neurosurgical Clipping vs. Endovascular Coiling of Ruptured Intracranial Aneurysms -- 28. Withdrawal of Support in Intracerebral Hemorrhage because of Predicted Poor Prognosis May Lead to Self-Fulfilling Prophecy -- 29. rtPA for Intraventricular Hemorrhage -- 30. Grading of Ruptured Subarachnoid Hemorrhages -- SECTION 3: TRAUMATIC BRAIN INJURY -- 31. Glasgow Coma Scale -- 32. Albumin vs. Saline for Resuscitation after Traumatic Brain Injury -- 33. Decompressive Craniectomy in Traumatic Brain Injury -- 34. Antiepileptic Drugs after Traumatic Brain Injury -- 35. Intracranial Pressure Monitoring in Traumatic Brain Injury -- 36. Amantadine for Recovery of Consciousness after Traumatic Brain Injury -- 37. Functional Imaging in Vegetative States -- 38. Corticosteroids for Traumatic Brain Injury -- 39. Corticosteroids in Acute Spinal Cord Injury -- SECTION 4: NEUROLOGIC INTENSIVE CARE -- 40. Midline Shift and Level of Consciousness -- 41. Use of Hyperosmolar Therapy for Cerebral Edema -- 42. Hyperventilation for Acute Intracranial Pressure Elevation -- 43. Temperature Management for Cardiac Arrest in Adults -- 44. Early Mobilization in the Intensive Care Unit -- SECTION 5: NEUROINFECTIOUS DISEASES -- 45. Glucocorticoids for Bacterial Meningitis in Adults -- 46. Acyclovir for Herpes Simplex Encephalitis -- 47. Polymerase Chain Reaction Testing for Herpes Simplex Encephalitis -- 48. Antifungal Therapy for Cryptococcal Meningitis -- 49. Guidelines for Treatment of Lyme Disease in the Nervous System -- SECTION 6: NEURO-ONCOLOGY -- 50. Temozolomide for Glioblastoma."]
[{"$nulls":4},"51. Surgery for Brain Metastases -- 52. Chemotherapy for Low-Grade Glioma -- 53. NovoTTF for Newly Diagnosed Glioblastoma -- 54. Bevacizumab for Recurrent Glioblastoma -- 55. Methotrexate for Primary CNS Lymphoma -- SECTION 7: NEUROMUSCULAR -- 56. Acute Treatment for Guillain-Barre Syndrome -- 57. Alternate Day Prednisone in Myasthenia Gravis -- 58. IVIg vs. Prednisone for Chronic Inflammatory Demyelinating Polyneuropathy -- 59. Glucocorticoid Steroids for Duchenne Muscular Dystrophy -- 60. Riluzole in Amyotrophic Lateral Sclerosis -- 61. Thymectomy in Myasthenia Gravis -- SECTION 8: MOVEMENT DISORDERS -- 62. L-Dopa for Parkinson's Disease -- 63. Deep Brain Stimulation for Parkinson's Disease -- 64. Deep Brain Stimulation for Dystonia -- 65. L-Dopa vs. MAO-B Inhibitors in Parkinson's Disease -- 66. Propranolol Treatment for Essential Tremor -- 67. Rasagiline in Parkinson's Disease -- 68. Botulinum a Toxin for Dystonia -- SECTION 9: MULTIPLE SCLEROSIS -- 69. Progressive Multifocal Leukoencephalopathy after Treatment with Natalizumab -- 70. Glucocorticoids for Optic Neuritis: The Optic Neuritis Treatment Trial -- 71. Neuromyelitis Optica Antibody in the Diagnosis of Neuromyelitis Optica -- 72. Correlation Between MRI Findings and Disability in Multiple Sclerosis -- 73. The Association of Vitamin D Levels and Multiple Sclerosis -- 74. Rate of Pregnancy-Related Relapse in Multiple Sclerosis -- SECTION 10: AUTOIMMUNE NEUROLOGY -- 75. EULAR Recommendations for Treatment of Primary CNS Vasculitis -- 76. NMDA-ab Receptor Encephalitis with Ovarian Teratoma -- 77. Identification of Sjogren's Syndrome Associated Ganglionopathy -- 78. IVIG for Stiff Person Syndrome -- SECTION 11: EPILEPSY -- 79. Lorazepam for Treatment of Status Epilepticus -- 80. "]
[{"$nulls":4},"Magnesium for the Prevention of Eclampsia -- 81. Antiepileptic Drug Treatment after a First Unprovoked Seizure."]
[{"$nulls":4},"82. Intravenous vs. Intramuscular Benzodiazepines for Status Epilepticus -- 83. Continuous EEG Monitoring for Evaluation of Nonconvulsive Status Epilepticus -- SECTION 12: HEADACHE AND PAIN -- 84. Sumatriptan for Migraine -- 85. Topiramate for Migraine Prevention -- 86. Duloxetine for Chemo-Induced Painful Neuropathy -- 87. Pregabalin for Neuropathic Pain -- 88. Amitriptyline Prophylaxis for Headache -- 89. Divalproex for Migraine Prophylaxis -- SECTION 13: COGNITIVE NEUROLOGY -- 90. Donepezil for Alzheimer's Disease -- 91. Memantine in Addition to Donepezil for Alzheimer's Disease -- 92. Rivastigmine for Dementia with Lewy Bodies -- 93. Melatonin for REM Sleep Behavior Disorder -- 94. Agitation in Dementia -- SECTION 14: PEDIATRIC NEUROLOGY -- 95. Treatment of Infantile Spasms -- 96. Pharmaco vs. Behavioral Therapy for ADHD -- 97. Ketogenic Diet for the Treatment of Childhood Epilepsy -- 98. Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy -- 99. Febrile Seizures -- 100. When to Stop Antiepileptic Drugs in Children with Epilepsy -- INDEX."]
[null,"2.","Record Nr.",null,"UNISA996344240903316"]
[null,null,"Autore",null,"Birkmann Andrea"]
[null,null,"Titolo",null,"Die Anknüpfung der originären Inhaberschaft am Urheberrecht : ein Vergleich der Rechtslage in Deutschland, Frankreich und den USA unter Berücksichtigung internationaler Konventionen / / Andrea Birkmann"]
[null,null,"Pubbl/distr/stampa",null,"Baden-Baden, Germany : , : Nomos, , 2009"]
[null,null,"ISBN",null,"3-8452-1639-5"]
[null,null,"Edizione",null,"[1.Auflage.]"]
[null,null,"Descrizione fisica",null,"1 online resource (310 pages)"]
[null,null,"Collana",null,"Abhandlungen zum Urheber- und Kommunikationsrecht ; ; Bd. 52"]
[null,null,"Disciplina",null,"340.94820943"]
[null,null,"Soggetti",null,"Droit d'auteur"]
[{"$nulls":4},"copyright"]
[{"$nulls":4},"Droit international privé"]
[{"$nulls":4},"Conflit de lois"]
[{"$nulls":4},"private international law"]
[{"$nulls":4},"Conventions internationales"]
[{"$nulls":4},"international convention"]
[{"$nulls":4},"UE/CE Droit"]
[{"$nulls":4},"EU law"]
[{"$nulls":4},"Droit comparé"]
[{"$nulls":4},"comparative law"]
[{"$nulls":4},"Germany"]
[{"$nulls":4},"France"]
[{"$nulls":4},"United States"]
[{"$nulls":4},"Allemagne RF"]
[{"$nulls":4},"Etats-Unis d'Amérique"]
[null,null,"Lingua di pubblicazione",null,"Tedesco"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,null,"Sommario/riassunto","\"In den vergangenen Jahren hat die grenzüberschreitende Nutzung urheberrechtlich geschützter Werke stark zugenommen. Dabei ist neben der Frage der internationalen Zuständigkeit der Gerichte auch das internationalprivatrechtliche Problem des materiell anwendbaren Rechts in den Mittelpunkt der Aufmerksamkeit gerückt. Besonders kontrovers diskutiert wird dieses hinsichtlich der Bestimmung der originären Inhaberschaft am Urheberrecht. Das Werk beschäftigt sich "]
[{"$nulls":4},"mit der kollisionsrechtlichen Behandlung dieses Aspektes bei Sachverhalten mit grenzüberschreitenden Bezügen. Nach einer wissenschaftlichen Hinterfragung der im internationalen Urheberrecht diskutierten Grundprinzipien der Anknüpfung an die lex loci protectionis einerseits und die lex originis andererseits und einer Darstellung der Rechtslage in Deutschland, Frankreich und den USA wird eine Kollisionsregel entwickelt, welche trotz der unterschiedlichen nationalen Ansätze einen einheitlichen, internationalen Ansatz bilden könnte. Dabei spielen auch die Vorgaben der internationalen Abkommen und des Europäischen Rechts eine Rolle.\"--Verl."]